PIII P3 Health Partners Inc.
Services-Health Services · Nasdaq · SEC CIK 1832511 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.5%
TTM net income YoY60.9%
TTM EPS YoY47.3%
Revenue 3-yr CAGR9.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-5.2%
Net margin-3.3%
FCF margin—
EBITDA margin0.2%
Returns
ROE-115.7%
ROA-7.6%
ROIC (approx.)-33.7%
Asset turnover2.30x
Leverage & solvency
Liabilities / assets70.0%
Debt / equity1.14x
Current ratio0.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.26x
Accruals ratio9.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20242025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20202020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | $491.06M |
| SG&A expense | $106.31M | $112.60M | $122.36M | $157.28M | $53.39M |
| Operating income | -$270.30M | -$320.66M | -$167.93M | -$1.56B | -$28.59M |
| Pretax income | -$321.06M | -$305.99M | -$183.73M | -$1.56B | -$31.41M |
| Income tax | $2.02M | $4.39M | $2.69M | $1.86M | $0 |
| Net income | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -$31.41M |
| EBITDA | -$186.14M | -$234.60M | -$81.25M | -$1.47B | -$27.79M |
| EPS (basic) | -45.26 | -46.78 | -0.61 | -6.50 | — |
| EPS (diluted) | -45.26 | -54.06 | -0.63 | -6.50 | — |
| Weighted avg. shares (diluted) | 3.27M | 2.94M | 294.59M | 41.58M | — |
| Banking | |||||
| Net interest income | -$55.03M | -$22.17M | -$15.98M | -$11.40M | -$2.53M |
| Provision for credit losses | $3.00M | $0 | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $25.01M | $44.10M | $40.93M | $18.46M | $39.90M |
| Current assets | $133.08M | $184.14M | $166.02M | $100.69M | $90.88M |
| PP&E, net | $3.37M | $5.73M | $8.69M | $8.84M | $6.15M |
| Goodwill | — | — | — | $0 | $871,128 |
| Intangibles | $492.42M | $574.35M | $666.73M | $751.05M | — |
| Total assets | $656.64M | $783.42M | $860.97M | $876.57M | $106.44M |
| Current liabilities | $545.26M | $496.42M | $299.37M | $241.66M | $90.62M |
| Short-term debt | $45.04M | $75.16M | $0 | $0 | $89,988 |
| Long-term debt | $228.37M | $108.91M | $108.32M | $94.42M | $45.39M |
| Total debt | $273.41M | $184.06M | $108.32M | $94.42M | $45.48M |
| Total liabilities | $796.88M | $633.89M | $427.31M | $353.91M | $145.96M |
| Shareholders' equity | -$155.23M | $75.94M | $142.13M | $5.85M | $22,714 |
| Net debt | $248.40M | $139.96M | $67.39M | $75.96M | $5.57M |
| Cash flow statement | |||||
| Operating cash flow | -$91.24M | -$110.13M | -$76.03M | -$126.02M | -$24.60M |
| Capital expenditure | — | $0 | $1.83M | $2.23M | $2.93M |
| Free cash flow | — | -$110.13M | -$77.86M | -$128.25M | -$27.52M |
| Investing cash flow | $129,000 | $14.53M | -$1.83M | -$7.73M | -$3.17M |
| Financing cash flow | $72.81M | $98.77M | $100.33M | $11.38M | $34.76M |
| Depreciation & amortization | $84.16M | $86.06M | $86.67M | $87.29M | $795,172 |
| Stock-based compensation | $5.58M | $5.75M | $5.98M | $19.40M | $447,475 |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.